Stay updated on Abemaciclib Combinations in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Abemaciclib Combinations in Pancreatic Cancer Clinical Trial page.

Latest updates to the Abemaciclib Combinations in Pancreatic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedSite revision updated from v3.4.1 to v3.4.2; there are no user-impacting changes to the study page content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.4.1 is now displayed, replacing the previous v3.4.0.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 in the page footer; no changes to study content, eligibility criteria, or navigation were observed.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded a consolidated Locations section with state-level locations (Connecticut, Illinois, Missouri, New Hampshire, Pennsylvania, Tennessee, Washington, Wisconsin) and removed the separate Connecticut Locations, Illinois Locations, Missouri Locations, New Hampshire Locations, Pennsylvania Locations, Tennessee Locations, Washington Locations, Wisconsin Locations; revised the page to v3.3.3.SummaryDifference0.7%

- Check91 days agoChange DetectedPubMed publications note updated to indicate auto-filling from PubMed, and the page revision is updated to v3.3.2.SummaryDifference0.1%

- Check99 days agoChange DetectedDeleted the government funding operating status notice from the page; all other study content remains unchanged.SummaryDifference0.3%

Stay in the know with updates to Abemaciclib Combinations in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abemaciclib Combinations in Pancreatic Cancer Clinical Trial page.